{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:52:37Z","timestamp":1788173557393,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006389","name":"University of Geneva","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hemodialysis-associated bloodstream infections (BSIs) represent a significant burden for patients. Understanding the trends in BSIs among hemodialysis patients is crucial for informing strategies to reduce their incidence and improve patient outcomes. This study aimed to evaluate secular trends, identify causative organisms, assess resistance patterns, and determine the sources of hemodialysis-associated BSIs at Geneva University Hospitals, where <jats:italic>Staphylococcus aureus<\/jats:italic> screening and decolonization of hemodialysis patients have been implemented since the year 2000.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A longitudinal cohort study was conducted using data from 2006 to 23. We included all patients receiving maintenance hemodialysis treatment at our institution. A hemodialysis-associated BSI was defined as BSI occurring during active hemodialysis treatment and diagnosed either during hospital admission or in outpatient hemodialysis unit. Outcomes included incidence rates of hemodialysis-associated BSIs, trends in causative pathogens, sources, and resistant organisms. Poisson regression was used to model trends over time of incidence rate ratios (IRR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 313 true BSI episodes were identified in 218 hemodialysis patients over 11,413 patient-hemodialysis months. The overall BSI incidence rate was 2.7 episodes per 100 patient-hemodialysis-months, with a consistent decrease over time. Compared to 2006-08, hemodialysis-associated BSI rates decreased by 16% in 2009-11 (IRR 0.84, 95% confidence interval [CI] 0.60\u20131.18), and by a maximum of 44% in 2021-23 (IRR 0.56, 95% CI 0.36\u20130.83). The decreasing trend was mainly due to reduced <jats:italic>S. aureus<\/jats:italic> BSIs, while Enterobacterales BSIs rates remained stable. Catheter-related BSIs accounted for 41.5% of infections (130\/313), with marked reduction following 2014. BSIs caused by resistant bacteria were rare, with decreasing trends of methicillin-resistant <jats:italic>S. aureus<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Hemodialysis-associated BSI rates significantly declined, driven largely by reductions in <jats:italic>S. aureus<\/jats:italic> BSIs and catheter-related infections. No replacement by Gram-negative BSI was observed. Prevention of hemodialysis-associated BSI is key for reducing infection burden among hemodialysis patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13756-025-01620-8","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T22:54:12Z","timestamp":1755644052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Secular trends of bloodstream infections in hemodialysis patients: insights from a longitudinal Swiss study"],"prefix":"10.1186","volume":"14","author":[{"given":"Nasreen","family":"Hassoun-Kheir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Buetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jaques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Noelle","family":"Chraiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlieke EA","family":"de Kraker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Schrenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Saudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Harbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"5","key":"1620_CR1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1053\/j.ajkd.2023.03.018","volume":"82","author":"CH Chong","year":"2023","unstructured":"Chong CH, Au EH, Davies CE, Jaure A, Howell M, Lim WH, et al. Long-term trends in Infection-Related mortality in adults treated with maintenance Dialysis. Am J Kidney Dis. 2023;82(5):597\u2013607. https:\/\/doi.org\/10.1053\/j.ajkd.2023.03.018","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1620_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12882-023-03442-5","volume":"25","author":"M Schamroth Pravda","year":"2024","unstructured":"Schamroth Pravda M, Maor Y, Brodsky K, Katkov A, Cernes R, Schamroth Pravda N, et al. Blood stream infections in chronic Hemodialysis patients - characteristics and outcomes. BMC Nephrol. 2024;25(1):3. https:\/\/doi.org\/10.1186\/s12882-023-03442-5","journal-title":"BMC Nephrol"},{"issue":"4","key":"1620_CR3","doi-asserted-by":"publisher","first-page":"e0124547","DOI":"10.1371\/journal.pone.0124547","volume":"10","author":"L Skov Dalgaard","year":"2015","unstructured":"Skov Dalgaard L, N\u00f8rgaard M, Jespersen B, Jensen-Fangel S, \u00d8stergaard LJ, Sch\u00f8nheyder HC, et al. Risk and prognosis of bloodstream infections among patients on chronic hemodialysis: A Population-Based cohort study. PLoS ONE. 2015;10(4):e0124547. https:\/\/doi.org\/10.1371\/journal.pone.0124547","journal-title":"PLoS ONE"},{"key":"1620_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12879-015-0907-y","volume":"15","author":"D Fram","year":"2015","unstructured":"Fram D, Okuno MF, Taminato M, Ponzio V, Manfredi SR, Grothe C, et al. Risk factors for bloodstream infection in patients at a Brazilian Hemodialysis center: a case-control study. BMC Infect Dis. 2015;15:158. https:\/\/doi.org\/10.1186\/s12879-015-0907-y","journal-title":"BMC Infect Dis"},{"key":"1620_CR5","doi-asserted-by":"publisher","unstructured":"Nguyen DB, Arduino MJ, Patel PR. Hemodialysis-Associated infections. Chronic kidney disease. Dialysis Transplantation. 2019:389\u2013e4108. https:\/\/doi.org\/10.1016\/B978-0-323-52978-5.00025-2","DOI":"10.1016\/B978-0-323-52978-5.00025-2"},{"issue":"1","key":"1620_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.ackd.2019.01.004","volume":"26","author":"M Syed-Ahmed","year":"2019","unstructured":"Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis. 2019;26(1):8\u201315. https:\/\/doi.org\/10.1053\/j.ackd.2019.01.004","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"1620_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ajic.2003.05.007","volume":"32","author":"G Taylor","year":"2004","unstructured":"Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S. Incidence of bloodstream infection in multicenter inception cohorts of Hemodialysis patients. Am J Infect Control. 2004;32(3):155\u201360. https:\/\/doi.org\/10.1016\/j.ajic.2003.05.007","journal-title":"Am J Infect Control"},{"issue":"5","key":"1620_CR8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1053\/j.ajkd.2014.11.030","volume":"65","author":"LS Dalrymple","year":"2015","unstructured":"Dalrymple LS, Mu Y, Romano PS, Nguyen DV, Chertow GM, Delgado C, et al. Outcomes of infection-related hospitalization in medicare beneficiaries receiving in-center Hemodialysis. Am J Kidney Dis. 2015;65(5):754\u201362. https:\/\/doi.org\/10.1053\/j.ajkd.2014.11.030","journal-title":"Am J Kidney Dis"},{"key":"1620_CR9","unstructured":"CDC. Surveillance summary of bloodstream infections (BSI) in outpatient Hemodialysis Facilities \u2014. National Healthcare Safety Network; 2019. pp. 2014\u20139."},{"issue":"2","key":"1620_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1053\/j.ajkd.2013.03.011","volume":"62","author":"PR Patel","year":"2013","unstructured":"Patel PR, Yi SH, Booth S, Bren V, Downham G, Hess S, et al. Bloodstream infection rates in outpatient Hemodialysis facilities participating in a collaborative prevention effort: a quality improvement report. Am J Kidney Dis. 2013;62(2):322\u201330. https:\/\/doi.org\/10.1053\/j.ajkd.2013.03.011","journal-title":"Am J Kidney Dis"},{"key":"1620_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jhin.2023.01.019","volume":"135","author":"N Hassoun-Kheir","year":"2023","unstructured":"Hassoun-Kheir N, Buetti N, Olivier V, Perez M, Frossard J, Renzi G, et al. Targeted mupirocin-based decolonization for Staphylococcus aureus carriers and the subsequent risk of mupirocin resistance in haemodialysis patients - a longitudinal study over 20 years. J Hosp Infect. 2023;135:55\u20138. https:\/\/doi.org\/10.1016\/j.jhin.2023.01.019","journal-title":"J Hosp Infect"},{"issue":"6","key":"1620_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5527\/wjn.v5.i6.489","volume":"5","author":"M Suzuki","year":"2016","unstructured":"Suzuki M, Satoh N, Nakamura M, Horita S, Seki G, Moriya K. Bacteremia in Hemodialysis patients. World J Nephrol. 2016;5(6):489\u201396. https:\/\/doi.org\/10.5527\/wjn.v5.i6.489","journal-title":"World J Nephrol"},{"issue":"1","key":"1620_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1542-4758.2006.01175.x","volume":"10","author":"MD Danese","year":"2006","unstructured":"Danese MD, Griffiths RI, Dylan M, Yu HT, Dubois R, Nissenson AR. Mortality differences among organisms causing septicemia in Hemodialysis patients. Hemodial Int. 2006;10(1):56\u201362. https:\/\/doi.org\/10.1111\/j.1542-4758.2006.01175.x","journal-title":"Hemodial Int"},{"issue":"11","key":"1620_CR14","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamainternmed.2021.5345","volume":"181","author":"N Buetti","year":"2021","unstructured":"Buetti N, Abbas M, Pittet D, de Kraker MEA, Teixeira D, Chraiti MN, et al. Comparison of routine replacement with clinically indicated replacement of peripheral intravenous catheters. JAMA Intern Med. 2021;181(11):1471\u20138. https:\/\/doi.org\/10.1001\/jamainternmed.2021.5345","journal-title":"JAMA Intern Med"},{"issue":"12","key":"1620_CR15","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1093\/ndt\/gfac205","volume":"37","author":"DA Jaques","year":"2022","unstructured":"Jaques DA, Ponte B, Haidar F, Dufey A, Carballo S, De Seigneux S, et al. Outcomes of incident patients treated with incremental haemodialysis as compared with standard haemodialysis and peritoneal Dialysis. Nephrol Dial Transpl. 2022;37(12):2514\u201321. https:\/\/doi.org\/10.1093\/ndt\/gfac205","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"1620_CR16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s15010-024-02469-6","volume":"53","author":"H Tolle","year":"2025","unstructured":"Tolle H, Nguyen A, MacPhail A, Hassoun-Kheir N, Chraiti MN, Boroli F, et al. Increased incidence of blood culture contaminations during and after the COVID-19 pandemic. Infection. 2025;53(2):711\u20136. https:\/\/doi.org\/10.1007\/s15010-024-02469-6","journal-title":"Infection"},{"key":"1620_CR17","volume-title":"Surveillance of healthcare-associated infections and prevention indicators in European intensive care units","author":"ECDC","year":"2017","unstructured":"ECDC. Surveillance of healthcare-associated infections and prevention indicators in European intensive care units. Stockholm: European Centre for Disease Prevention and Control; 2017."},{"key":"1620_CR18","unstructured":"SRRQAP. Swiss Renal Registry and Quality Assessment Program [Available from: https:\/\/www.swissnephrology.ch\/srrqap\/"},{"issue":"3","key":"1620_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0304-4076(90)90014-K","volume":"46","author":"AC Cameron","year":"1990","unstructured":"Cameron AC, Trivedi PK. Regression-based tests for overdispersion in the Poisson model. J Econ. 1990;46(3):347\u201364.","journal-title":"J Econ"},{"key":"1620_CR20","unstructured":"R-Core-Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria2020 [Available from: https:\/\/www.R-project.org\/"},{"issue":"1","key":"1620_CR21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12882-021-02537-1","volume":"22","author":"KP Kaur","year":"2021","unstructured":"Kaur KP, Chaudry MS, Fosb\u00f8l EL, \u00d8stergaard L, Torp-Pedersen C, Bruun NE. Temporal changes in cardiovascular disease and infections in Dialysis across a 22-year period: a nationwide study. BMC Nephrol. 2021;22(1):340. https:\/\/doi.org\/10.1186\/s12882-021-02537-1","journal-title":"BMC Nephrol"},{"issue":"4","key":"1620_CR22","doi-asserted-by":"publisher","first-page":"666","DOI":"10.2215\/cjn.13781217","volume":"13","author":"EMC D\u2019Agata","year":"2018","unstructured":"D\u2019Agata EMC. Addressing the problem of Multidrug-Resistant organisms in Dialysis. Clin J Am Soc Nephrol. 2018;13(4):666\u20138. https:\/\/doi.org\/10.2215\/cjn.13781217","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"1620_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1086\/502523","volume":"26","author":"SD Reed","year":"2005","unstructured":"Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2005;26(2):175\u201383. https:\/\/doi.org\/10.1086\/502523","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"1620_CR24","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2215\/cjn.11411116","volume":"12","author":"DB Nguyen","year":"2017","unstructured":"Nguyen DB, Shugart A, Lines C, Shah AB, Edwards J, Pollock D, et al. National healthcare safety network (NHSN) Dialysis event surveillance report for 2014. Clin J Am Soc Nephrol. 2017;12(7):1139\u201346. https:\/\/doi.org\/10.2215\/cjn.11411116","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1620_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12882-019-1253-x","volume":"20","author":"H Mohamed","year":"2019","unstructured":"Mohamed H, Ali A, Browne LD, O\u2019Connell NH, Casserly L, Stack AG, et al. Determinants and outcomes of access-related blood-stream infections among Irish haemodialysis patients; a cohort study. BMC Nephrol. 2019;20(1):68. https:\/\/doi.org\/10.1186\/s12882-019-1253-x","journal-title":"BMC Nephrol"},{"issue":"1","key":"1620_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2215\/cjn.06820619","volume":"15","author":"M Fisher","year":"2020","unstructured":"Fisher M, Golestaneh L, Allon M, Abreo K, Mokrzycki MH. Prevention of bloodstream infections in patients undergoing Hemodialysis. Clin J Am Soc Nephrol. 2020;15(1):132\u201351. https:\/\/doi.org\/10.2215\/cjn.06820619","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 1","key":"1620_CR27","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/j.ijantimicag.2007.06.021","volume":"30","author":"A Juan-Torres","year":"2007","unstructured":"Juan-Torres A, Harbarth S. Prevention of primary bacteraemia. Int J Antimicrob Agents. 2007;30(Suppl 1):S80\u20137. https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.06.021","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"1620_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1053\/j.ajkd.2013.08.019","volume":"63","author":"A Rosenblum","year":"2014","unstructured":"Rosenblum A, Wang W, Ball LK, Latham C, Maddux FW, Lacson E. Jr. Hemodialysis catheter care strategies: a cluster-randomized quality improvement initiative. Am J Kidney Dis. 2014;63(2):259\u201367. https:\/\/doi.org\/10.1053\/j.ajkd.2013.08.019","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1620_CR29","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.cmi.2024.01.020","volume":"30","author":"B Weikert","year":"2024","unstructured":"Weikert B, Kramer TS, Schwab F, Graf-Allgeier C, Wolke SI, Gastmeier P, et al. Effect of a multimodal prevention strategy on dialysis-associated infection events in outpatients receiving haemodialysis: the DIPS stepped wedge, cluster-randomized trial. Clin Microbiol Infect. 2024;30(9):1147\u201353. https:\/\/doi.org\/10.1016\/j.cmi.2024.01.020","journal-title":"Clin Microbiol Infect"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01620-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-025-01620-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01620-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:16:59Z","timestamp":1757438219000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01620-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1620"],"URL":"https:\/\/doi.org\/10.1186\/s13756-025-01620-8","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NHK has received partial funding support from Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 101034420 (Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance [PrIMAVeRa]) with support from the European Union\u2019s Horizon 2020 Research and Innovation Programme and EFPIA. All other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}